» Articles » PMID: 29102428

GnRHa Trigger and Luteal Coasting: a New Approach for the Ovarian Hyperstimulation Syndrome High-risk Patient?

Overview
Publisher Elsevier
Date 2017 Nov 6
PMID 29102428
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Final oocyte maturation using gonadotrophin-releasing hormone agonist (GnRHa) is increasingly common as it almost eliminates the risk of developing ovarian hyperstimulation syndrome (OHSS) in high-responder patients. The first studies using this approach showed a poor reproductive outcome when only vaginal progesterone was used as luteal phase support, due to the luteolysis that will develop as a result of LH withdrawal. Timely luteal administration of human chorionic gonadotrophin (HCG) will counterbalance the low LH concentrations and therefore maintain progesterone production from the corpora lutea, however, some patients with a high number of follicles will develop OHSS using this approach. The concept of 'luteal coasting' transfers the experience from follicular phase coasting for OHSS prevention to the early luteal phase for patients having fresh transfers. Daily monitoring of progesterone concentrations is required and a rescue HCG bolus can be administered, once progesterone concentrations drop below 30 nmol/l. This approach reduces the risk of OHSS development in high-responder patients undergoing fresh embryo transfer, without negatively impacting the reproductive outcome.

Citing Articles

Severe Ovarian Hyperstimulation Syndrome in a Woman With Breast Cancer Under Letrozole Triggered With GnRH Agonist: A Case Report and Review of the Literature.

Iorio G, Rovetto M, Conforti A, Carbone L, Vallone R, Cariati F Front Reprod Health. 2022; 3:704153.

PMID: 36303992 PMC: 9580822. DOI: 10.3389/frph.2021.704153.


Systematic Review of Ovarian Activity and Potential for Embryo Formation and Loss during the Use of Hormonal Contraception.

Harrison D, Buskmiller C, Chireau M, Ruppersberger L, Yeung Jr P Linacre Q. 2020; 85(4):453-469.

PMID: 32431378 PMC: 6322118. DOI: 10.1177/0024363918815611.


Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.

Castillo J, Haahr T, Martinez-Moya M, Humaidan P Ups J Med Sci. 2020; 125(2):131-137.

PMID: 32366146 PMC: 7721056. DOI: 10.1080/03009734.2020.1736696.


Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation-A Retrospective Proof-of-Concept Study.

Lawrenz B, Samir S, Garrido N, Melado L, Engelmann N, Fatemi H Front Endocrinol (Lausanne). 2018; 9:33.

PMID: 29497400 PMC: 5818401. DOI: 10.3389/fendo.2018.00033.